| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $105.8M | -6.8% |
| Cost of Revenue | $3.9M | -16.2% |
| Gross Profit | $101.9M | -6.4% |
| R&D Expense | $12.0M | -12.7% |
| SG&A Expense | $16.1M | +9.9% |
| Operating Income | $16.2M | +124.0% |
| Pre-tax Income | $23.2M | +130.2% |
| Income Tax | $5.3M | -37.5% |
| Net Income | $17.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.8M | -64.7% |
| Short-term Investments | $14.9M | — |
| Accounts Receivable | $19.6M | +29.2% |
| Inventory | $6.3M | +48.0% |
| Current Assets | $64.8M | +13.2% |
| Total Assets | $125.4M | +7.6% |
| Current Liabilities | $19.5M | -2.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.6M | -114.1% |
| Capital Expenditures | $2.3M | -72.8% |
| Investing Cash Flow | -$19.9M | -0.6% |
| Financing Cash Flow | $2.1M | -15.9% |
| Free Cash Flow | -$6.0M | -134.3% |
| +120.9% |
| EPS (Basic) | $0.14 | +109.9% |
| EPS (Diluted) | $0.05 | +103.5% |
| Total Liabilities |
| $27.0M |
| -29.1% |
| Stockholders' Equity | $63.3M | +500.0% |